---
figid: PMC9019764__etm-23-05-11287-g03
pmcid: PMC9019764
image_filename: etm-23-05-11287-g03.jpg
figure_link: /pmc/articles/PMC9019764/figure/f4-ETM-23-5-11287/
number: Figure 4
figure_title: ''
caption: SIN inhibits phosphorylation of VEGFR2 and AKT in HUVECs. (A) SIN inhibits
  the phosphorylation of VEGFR2 induced by VEGF. The expression levels of p-VEGFR2
  and VEGFR2 in HUVECs treated with SIN were analyzed by western blotting. n=3, *P<0.05,
  **P<0.01. (B) SIN inhibited VEGFR2-induced phosphorylation of AKT. p-AKT and AKT
  were examined in HUVECs following treatment with SIN. n=3, *P<0.05, **P<0.01. SIN,
  sinensetin; VEGFR, vascular endothelial growth factor receptor; HUVECs, human umbilical
  vein endothelial cells; VEGF, vascular endothelial growth factor; p-, phosphorylated.
article_title: Sinensetin suppresses angiogenesis in liver cancer by targeting the
  VEGF/VEGFR2/AKT signaling pathway.
citation: Xiao Li, et al. Exp Ther Med. 2022 May;23(5):360.
year: '2022'

doi: 10.3892/etm.2022.11287
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- sinensetin
- angiogenesis
- liver cancer
- human umbilical vascular endothelial cell
- molecular mechanism

---
